filings.toolsItem 1A. Risk Factors
2K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors
There have been no material changes to the risk factors as previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2022.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
On August 3, 2022, we publicly announced that our Board of Directors authorized the repurchase of up to an aggregate of $500 million of our outstanding common stock in one or more open market and/or privately negotiated transactions. The repurchase authorization does not have an expiration date. We repurchased the following shares of our common stock during the second quarter of 2023 under this repurchase authorization:
| Period | Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in thousands) | ||||||||||||||||||||||
| April 1 - 30, 2023 | — | $ | — | — | $ | 397,637 | ||||||||||||||||||||
| May 1 - 31, 2023 | 15,570 | $ | 5,664.19 | 15,570 | $ | 309,445 | ||||||||||||||||||||
| June 1 - 30, 2023 | 19,257 | $ | 5,862.04 | 19,257 | $ | 196,560 | ||||||||||||||||||||
| Total | 34,827 | $ | 5,773.58 | 34,827 |
On August 2, 2023, the Board of Directors approved an additional repurchase authorization of up to an aggregate of $500 million. The repurchase authorization does not have an expiration date.
Previous: Item 4. Controls and Procedures · Next: Item 6. Exhibits